T-CURX announces senior leadership appointments
T-CURX completes formation of highly experienced clinical team to rapidly advance clinical translation of its next-generation CAR-T cell therapies
08-Jun-2023 -
T-CURX GmbH announces the appointment of Professor Michael Hudecek, MD, co-founder of T-CURX and a member of its Scientific Advisory Board, as its new Chief Medical Officer (CMO), and the appointment of Karl Schumacher, MD, an industry-experienced MD with many years of experience in conducting ...
appointments
cancer
cancer therapy
+2